Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West Virginia ...
Inhaled steroids aren’t the go-to treatment for COPD, so your doctor will likely prescribe a bronchodilator, too. This is medicine in an inhaler that relaxes your airway muscles to help you breathe ...
Abstract: Sixth-generation (6G) mobile communication networks are expected to have dense infrastructures, large antenna size, wide bandwidth, cost-effective hardware, diversified positioning methods, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results